The AI in Business Podcast

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj Artificial Intelligence Research CEO Daniel Faggella interviews top AI executives from Fortune 500 firms and unicorn startups - to uncover trends, use-cases, and best practices for practical AI adoption.

Subscribe to Emerj's weekly AI newsletter by downloading our "Beginning with AI" PDF guide

Improving Drug Development Speed with AI in Life Sciences - with Emmanuel Walckenaer of YSEOP

Mar 8, 2022

Today’s guest is Emmanuel Walckenaer, CEO of YSEOP. YSEOP is a natural language generation AI vendor serving life sciences and drug development. In today’s episode, Emmanuel speaks about speeding up the drug development process through the lens of the life sciences industry being in extreme flux and what happens...

Medical Device AI at the Edge - Use-Cases and Challenges - with Patrick Bangert of Samsung SDS

Sep 14, 2021

Today’s guest is Patrick Bangert, VP of Artificial Intelligence at Samsung SDS, the services wing at Samsung. With $200B in annual revenue, Samsung is the 15th largest company in the world according to the Global 500. Today, Patrick discusses the use-cases of AI at the edge in medical imagery and how the healthcare...

Personalized Medicine Before and After AI - with Alexandre Le Bouthillier of Imagia

Aug 31, 2021

Our guest this week is Alexandre Le Bouthillier, Co-Founder of Imagia. Imagia is a firm based in Montreal that leverages artificial intelligence for medical analysis. Today, Alexandre discusses personalized medicine before and after artificial intelligence. He also brings to bear his perspectives on how personalized...

Unlocking Data's Value in Life Sciences, from Diagnosis to Telehealth and Beyond - with Bill Fox of SambaNova

Aug 19, 2021

Today’s guest is Bill Fox, Business Development Executive for Healthcare Strategy at SambaNova Systems. Founded in Palo Alto, California, SambaNova offers hardware, software, DataFlow-as-a-Service, and more. Today, Bill speaks about what SambaNova’s team is seeing in terms of near-term future opportunities for...

Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

Jul 27, 2021

Today’s guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses...